Clinical Trial

The Therapeutic Effect of Betaine in Syringomyelia

Name: The Therapeutic Effect of Betaine in Syringomyelia — clinical trial record (NCT06308367)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

Purpose: This clinical trial aims to evaluate the indications, therapeutic effects and side effects of betaine in refractory syringomyelia. Primary outcome measure: The primary endpoint is the change of ASIA at week 12. The clinical efficacy is defined as ASIA increase ≥ 1 at week 12, as compared with that before betaine usage.

Trial Details

NCT Number	NCT06308367
Lead Sponsor	Xuanwu Hospital, Beijing
Conditions	Syringomyelia
Enrollment	30 participants
Start Date	2024-03
Primary Completion	2027-03 (estimated)
Study Completion	2028-03 (estimated)
Updated on ClinicalTrials.gov	2024-03-13